查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球创伤产品市场-2022-2029
市场调查报告书
商品编码
1140715

全球创伤产品市场-2022-2029

Global Trauma Products Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

创伤产品的市场规模预计在 2021 年达到 81.49 亿美元，到 2029 年达到 132.67 亿美元，在预测期间（2022-2029 年）以 6.5% 的复合年增长率增长据说，

创伤是突然发生并需要立即就医的任何身体伤害，例如骨折、烧伤、扭伤、脱臼和拉伤。市场主要由创伤产品的可用性主导，例如内固定器、外固定器、运动医学设备、笼子、角刀片、电动工具和弧形棒。

市场动态

全球创伤产品市场正在增长，这得益于多种因素，包括全球范围内遭受创伤的人数不断增加、新创伤产品的批准以及新技术的进步。

创伤发病率的上升和各种新技术的进步预计将推动市场增长。

对创伤产品不断增长的需求推动了市场的发展，并增加了全球遭受创伤的人数。根据世界卫生组织 (WHO) 的数据，全世界每年约有 500 万人死于创伤性伤害，例如交通事故、溺水、中毒、跌倒和烧伤、袭击和自残以及战争行为造成的暴力。每年约有 30% 的 65 岁及以上的人跌倒，约 40% 的 75 岁及以上的人跌倒。大约 40-60% 的跌倒导致受伤，10% 是重伤，5% 是骨折。

市场正在见证创伤诊断产品的技术进步，以改善脑损伤的检测。例如，Medicortex 目前正在开发快速诊断试剂盒，以检测来自尿液和唾液的脑震盪和轻度创伤性脑损伤。这种快速诊断试剂盒基于脑损伤后体液中发现的特定生物标誌物。这种快速诊断试剂盒可以帮助提高对脑损伤的检测，尤其是对有害且难以通过现代手段诊断的轻微脑损伤。正在开发基于聚醣的生物标誌物，用于检测轻度创伤性脑损伤。

预计在预测期内，对新型创伤产品的批准不断增加将刺激市场增长。例如，2019 年 12 月，OrthoGrid Systems, Inc. 获得了美国食品药品监督管理局（Food and Drug Administration）（ FDA ）的 PhantomMSK Trauma 批准。 OrthoGrid Systems 的 PhantomMSK 是一个通用软件平台，可与所有製造商的仪器在多个程序中协同工作，以帮助进行透视植入物、仪器和解剖对齐。在骨科手术中，唯一能有效纠正由外部电磁干扰引起的图像失真现象的术中对齐技术，以及平面图像映射到弯曲的输入荧光团，影响图像完整性并存在潜在的错位风险。

2020 年 1 月，vasopharm GmbH 完成了关键欧洲临床试验 NOSTRA III（创伤性脑损伤中的 NO 合□）的患者登记。 NOSTRA III 是一项 III 期临床试验，旨在测试 lonopternin (VAS203) 在中度至重度闭合性头部创伤性脑损伤 (TBI) 患者中的疗效和安全性。

预计缺乏熟练的专业人员和高昂的程序成本将阻碍市场增长。

这些程序的成本越来越高、缺乏熟练的专业人员以及缺乏对这些创伤产品的了解是可能在预测期内抑制市场增长的一些关键因素。

行业分析

全球创伤产品市场根据波特五力、监管分析、供应链分析和定价分析等各种行业因素对市场进行了深入分析。

细分分析

产品类型细分预计将占全球创伤产品市场的最大市场份额

创伤产品市场根据内部支架、外部支架和其他创伤产品进行细分。在市场细分中，内部夹具占据了最高的市场份额。内固定装置包括板、螺钉、钉子和其他内固定装置。更短的住院时间、更少的疤痕和瘀伤以及更快的患者康復等好处正在推动内固定装置的采用。 Accumed 的 Acu-Loc 2 手腕板系统提供 48 种板选项，包括远端和近端坐板、三个板扩展选项和片段特定板。它具有用于骨折管理和骨板定位的创新仪器。该系统用于恢復经历过骨折、融合或截骨术的人的腕骨的自然解剖结构。 Zimmer Natural Nail System 是下一代髓内钉系统，旨在简化手术前后的操作。有了这个系统，钉子的设计就尽可能地符合解剖学和对患者友好，并且器械的设计具有流畅的布局和直观的功能。

外固定器具有稳定受损骨骼加速癒合的作用，因此市场有望实现正增长。外固定器广泛用于治疗开放性骨折。外固定器是儿童骨折的首选，因为内固定器对骨骼生长无效。外固定器包括单侧固定器、双侧固定器、圆形固定器和混合固定器。圆形固定器在不推荐内固定的长骨骨折中显示出很高的疗效。

此外，市场按手术部位分为上肢和下肢。由于越来越多地采用下肢创伤产品，下肢市场份额最高。摩托车事故通常会导致严重的脚踝、脚和大腿受伤。下肢包括臀部和骨盆、小腿、足部和脚踝、大腿和膝盖的损伤。

由于骨科疾病和运动相关损伤的增加，对上肢创伤产品的需求增加，预计上肢市场将增长。上肢包括手、手腕、肩膀、手臂和肘部受伤。越来越多的公司还提供上肢创伤产品。例如，Zimmer Biomet 为上肢的复杂解剖学和生理学提供范围广泛的骨折固定产品。该产品由具有先进技术的植入物和仪器组成，可增强固定、简化程序并提高准确性。

区域分析

北美占全球创伤产品市场的最大份额。

按地区分为北美、南美、欧洲、亚太地区、中东和非洲。尤其是北美，由于植入物和设备等产品的高采用率，在创伤产品市场上占据主导地位。随着事故案件的增加，遭受外伤的人数也在增加。有许多处理紧急情况的创伤中心。由于技术进步和对新产品的日益认可以及优惠的报销政策，美国拥有最高的市场份额。几家製药和生物技术公司正在努力提高人们对创伤的认识。例如，2019 年 12 月，Kaiser Permanent 与健康一代和探索教育联盟合作，在全美 25,000 所学校解决创伤和压力问题，促进社会和情感健康。该计划将为教师提供技能和资源，以支持学生的心理健康并成功管理自己的情感需求。

由于创伤产品研发活动的增加，预计亚太地区的市场将出现强劲增长。开发创伤产品的公司数量正在增加。由于老年人口不断增长，包括印度和中国在内的国家预计将出现显着增长，因为老年人受伤的风险更高。随着人均医疗支出、医疗支出和私人保险支出的增加，预计在预测期内对创伤护理产品的需求也将增加。

竞争格局

创伤医学市场是一个竞争激烈的市场，拥有多个国际和国内市场。产品多样化、收入安全和商机使市场更具竞争力。 Medtronic Plc、Cardinal Health Inc、Stryker Corporation、Smith &Nephew、Depuy Synthes（隶属于 Johnson &Johnson）、Wright Medical Group N.V、B. Braun Melsungen AG 和 Arthrex, Inc. 是具有重要市场份额的主要市场参与者 我在这里.

主要参与者专注于产品批准、产品开发、市场开发、专利申请和技术进步等战略，以保持其市场地位。例如，2019 年 9 月，Allied Corp 就大麻素和□类药物组合物以及治疗创伤后应激障碍 (PTSD) 的方法提交了美国临时专利申请。

公司正在通过合作、合併、战略合作伙伴关係和收购在全球范围内扩张，以增加对创伤产品的需求。例如，2019 年 11 月，Stryker Corporation 签订了最终协议，以每股 30.75 美元的价格收购 Wright Medical Group 100% 的已发行股份。收购 Wright Medical 将加强 Stryker 在市场上的创伤和四肢业务。

2020 年 1 月，ATAI Life Sciences AG 与 Neuronasal Inc. 建立合作伙伴关係，以开发一种用于轻度创伤性脑损伤 (mTBI) 或脑震荡的短期治疗方法。

2019 年 12 月，Therapeutic Solutions International 获得专利成人干细胞的独家授权，以治疗运动和田径领域的慢性创伤性脑病 (CTE) 和创伤性脑损伤 (TBI) 签署了一份意向书。

2020 年 1 月，Anika Therapeutics, In 同意收购领先的私营运动医学公司 Parcus Medical 和领先的私营活动患者关节表面保存解决方案 Arthrosurface。这些收购将有助于扩大公司用于关节保护和修復的替代和再生疗法产品组合。

值得关注的重点公司

美敦力PLC

概述 Medtronic, Inc. 是一家在美国运营的医疗器械製造和销售公司，总部位于美国明尼阿波利斯。它在大约 140 个国家开展业务，拥有 90,000 名员工。

按产品类型划分的投资组合。

VARILOC：VARILOC 锁定加压钢板系统具有角度稳定锁定钢板的优势，可更好地固定骨质疏鬆症和干□端骨折。与传统的板螺钉方法相比，锁定机构还确保了血液供应。在美敦力-康辉创伤产品下开发。

重大进展。 2022 年 5 月，医疗保健技术领导者 Medtronic plc 宣布收购 Intersect ENT。他们将通过一系列创新产品扩大公司的耳鼻喉产品组合。

全球创伤产品市场报告提供大约 45 多个市场数据表、40 多个数字和 180 页内容。

内容

第1章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第 4 章市场动态

  • 市场影响因素
    • 驱动程序
      • 创伤发生率增加
      • 技术进步的增加
    • 限制因素
      • 缺乏熟练的员工
      • 治疗费用高
    • 商机
    • 影响分析

第5章行业分析

  • 波特五力分析
  • 监管分析
  • 供应链分析
  • 定价分析

第 6 章按产品类型分析

  • 内固定器
    • 盘子
    • 螺丝
    • 钉子
    • 其他内部固定装置
  • 外部夹具
    • 单侧和双侧固定
    • 圆形固定器
    • 混合夹具
  • 其他创伤产品

第 7 章按手术部位

  • 上肢
    • 手/手腕
    • 肩部
    • 武器
    • 弯头
  • 下肢
    • 髋关节和骨盆
    • 下肢
    • 脚/脚踝
    • 大腿
    • 膝盖

第 8 章最终用户

  • 医院和创伤中心
  • 门诊手术中心

第 9 章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 10 章竞争格局

  • 主要发展和战略
  • 公司份额分析
  • 按产品类型进行基准测试
  • 值得关注的重点公司列表

第 11 章公司简介

  • 美敦力公司
    • 公司概况
    • 按产品类型划分的产品组合和内容
    • 主要亮点
    • 财务摘要
  • Cardinal Health Inc.
  • Stryker Corporation
  • Smith & Nephew
  • Depuy Synthes（A part of Johnson & Johnson）
  • Zimmer Biomet Holdings Inc.
  • Integra Lifesciences Holdings Corporation
  • Wright Medical Group N.V
  • B. Braun Melsungen AG
  • Arthrex, Inc.

第12章 全球外伤用品市场-DataM

简介目录
Product Code: DMMD2395

Market Overview

Trauma Products Market size was valued US$ 8,149 million in 2021 and is estimated to reach US$ 13,267 million by 2029, growing at a CAGR of 6.5% during the forecast period (2022-2029).

Trauma is referred to as physical injuries, including fractures, burns, sprains, dislocations, and strains that occurred suddenly and required immediate medical attention. The market is dominated by the availability of trauma products, including internal fixators, external fixators, sports medicine devices, cages, angled blades, power tools, arc bars, and other trauma products.

Market Dynamics

The global trauma products market is growing due to several factors such as increasing the number of people undergoing traumatic injuries worldwide, approval of novel traumatic products and novel technological advances.

Rising incidence of traumatic injuries and various new technological advancements are expected to drive market growth.

The rising demand for trauma products drives the market, increasing the number of people undergoing traumatic injuries worldwide. According to the World Health Organization (WHO), approximately 5 million people die every year due to traumatic injuries including traffic collisions, drowning, poisoning, falls or burns, and violence from assault, self-inflicted violence, or acts of war worldwide. Every year approximately, 30% of people aged group 65 years or more fall, and around 40% of the aged group above 75 years fall. Around 40-60% of falls lead to injuries, 10% result in serious injuries, and 5% being fractured.

The market is witnessing technological advancement in diagnostic trauma products for improving the detection of brain injury. For instance, Medicortex is currently developing a rapid diagnostic kit to detect concussion and mild traumatic brain injury from urine or saliva. The rapid diagnostic kit is based on the specific biomarkers discovered from body fluids following brain injury. The rapid diagnostic kit would help improve the detection of brain injury, especially in mild cases that are harmful and difficult to diagnose by using contemporary means. It is being developed by using glycan-based biomarkers for the detection of mild traumatic brain injury.

The increase in the approval of novel trauma products shall stimulate market growth over the forecasted period. For instance, in December 2019, OrthoGrid Systems, Inc. had received clearance from the U.S. Food and Drug Administration (FDA) for the PhantomMSK Trauma. The OrthoGrid Systems' PhantomMSK is a universal software platform that works with all manufacturer devices across multiple procedures to assist with an implant, instrument, and anatomic alignment that use fluoroscopic imaging. It is the only intraoperative alignment technology effective in correcting the phenomenon of image distortion in orthopedic surgery, attributed to external electromagnetic interference and the mapping of the planar image on a curved input phosphor, affecting image integrity and causing potential risks of malalignment.

In January 2020, vasopharm GmbH completed the patient enrollment into the pivotal European NOSTRA III (NO Synthase in Traumatic Brain Injury) clinical trial. NOSTRA III is a Phase III clinical trial for examining the efficacy and safety of Ronopternin (VAS203) for the treatment of moderately to severely injured closed head traumatic brain (TBI) injury patients.

Scarcity of skilled professionals and high cost of procedures are expected to hamper the market growth.

High cost of these procedures that are increasing, scarcity of skilled professionals and unawareness about these trauma products are some key factors that may restraint the growth of market during the forecast period.

Industry Analysis

The global trauma products market provides in-depth analysis of the market based on various industry factors such as Porter's Five Forces, Regulatory Analysis, Supply Chain Analysis, Pricing Analysis.

Segment Analysis

Product type segment is expected to hold the largest market share in global trauma products market

The trauma products market is segmented based on internal fixators, external fixators, and other trauma products. The internal fixators segment accounts for the highest market share. The internal fixators segment includes the plates, screws, nails, and other internal fixators. There is higher adoption of the internal fixators due to their advantages in providing shorter hospital stay, less scarring and bruising, and early functionality for patients. Acumed's Acu-Loc 2 Wrist Plating System provides 48 plate options, including distal and proximal sitting plates, three different plate extension options, and fragment-specific plating choices. It features innovative instrumentation for fracture management and plate positioning. It is used to restore the natural anatomy of the wrist bones among people with fractures, fusions, and osteotomies. The Zimmer Natural Nail System is a next-generation intramedullary nailing system designed to make the surgery experience easy from pre-op to close. This system is used for designing the nails as anatomical and patient-conscious as possible, and instruments are designed to be fluid in layout and intuitive in function.

The external fixators are expected to have positive market growth due to their efficiency in speeding up the healing process by stabilizing the damaged bones. The external fixators are widely used for the treatment of open fractures. These external fixators are the preferred choice for fractures in children as internal fixators are not effective in growing bones. The external fixators include the unilateral & bilateral fixators, circular fixators, and hybrid fixators. Circular fixators have demonstrated high efficacy for long bone fractures where internal fixation is not recommended.

Further, the market is also classified based on the surgical site as upper extremities and lower extremities. The lower extremities segment accounts for the highest market share due to higher adoption of the lower extremities trauma product. The number of motorcycle accidents leads to severe injury to the ankle, foot, and thigh. The lower extremities segment includes the injury to the hip & pelvic, lower leg, foot & ankle, thigh, knee.

The upper extremities segment is expected to have positive market growth owing to the rising demand for upper extremities trauma products with the increasing prevalence of orthopedic diseases & sports-related injuries. The upper extremities segment includes the injury to the hand, wrist, shoulder, arm, and elbow. There is an increase in the number of companies providing upper extremities trauma products. For instance, Zimmer Biomet provides a wide range of fracture fixation products for the intricate anatomy and physiology of the upper extremities. It comprises implants and instruments with advanced technologies to enhance fixation, simplify, and improve the accuracy of procedures.

Geographical Analysis

North America region holds the largest market share in the global trauma products market

By region, the trauma products market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Among all of the regions, North America dominated the trauma products market due to the high rate of adoption rate products, including implants and devices. There is an increase in the number of people suffering from traumatic injuries with the rising accidental cases. There is a large number of trauma centers handling emergencies. The United States accounts for the highest market share due to the rise in the approval of novel products with technological advancement and the favorable reimbursement policy's availability. Several pharmaceutical and biotechnology companies are involved in creating awareness regarding the trauma. For instance, in December 2019, Kaiser Permanent had entered into a partnership with the Alliance for a Healthier Generation and Discovery Education to address trauma and stress and promote social and emotional wellness at 25,000 schools in the United States. This initiative would provide the teachers with the skills and resources to support students' mental health and better tend to their own emotional needs.

The Asia Pacific region is expected to have positive market growth due to increased research and development activities for trauma products. There is a rising number of companies developing trauma products. Substantial growth is expected to observe in the countries including India and China due to the increasing older population as older people are at a high risk of developing traumatic injuries. The demand for trauma products is expected to increase with the increasing per-capita healthcare, healthcare expenditure, and private insurance expenditure over the forecasted period.

Competitive Landscape

The trauma products market is highly competitive with the presence of several international and local markets. Product diversification, revenue generation, and opportunities intensify the market competition. Medtronic Plc, Cardinal Health Inc., Stryker Corporation, Smith & Nephew, Depuy Synthes (part of Johnson & Johnson), Wright Medical Group N.V, B. Braun Melsungen AG, and Arthrex, Inc. are the leading market players with significant market share.

The key players focus on product approval, product development, market expansion, patent filing, and technological advancement strategies for holding their position in the market. For instance, in September 2019, Allied Corp had filed the United States Provisional Patent Application for cannabinoid and terpenoid pharmaceutical compositions and methods for treating post-traumatic stress disorder (PTSD).

The companies are entering into collaborations, mergers, strategic partnerships, and acquisitions to increase the demand for trauma products and their expansion across the globe. For instance, in November 2019, Stryker corporation had entered into the definitive agreement to acquire 100% of the issued and outstanding right Medical Group shares for USD 30.75 per share. The acquisition of Wright Medical would strengthen Stryker's trauma and extremities business in the market.

In January 2020, ATAI Life Sciences AG had entered into the collaboration with Neuronasal Inc. to develop the short-term treatment for mild Traumatic Brain Injury (mTBI) or concussion.

In December 2019, Therapeutic Solutions International signed the Letter of Intent to license exclusive rights to a patented adult stem cell to treat chronic traumatic encephalopathy (CTE) and traumatic brain injury (TBI) in the field of sports and athletics.

In January 2020, Anika Therapeutics, In, agreed to acquire Parcus Medical, a leading, privately-held sports medicine company, and Arthrosurface, a leading, privately-held provider of joint surf preservation solutions for active patients. These acquisitions would help the company expand its portfolio into replacement and regenerative therapies for joint preservation and restoration.

Key Companies to Watch

Medtronic Plc:

Overview: Medtronic plc is an American company that operates in U.S. and manufactures and markets medical device headquartered in Minneapolis, US. It is operational in around 140 countries and 90,000 people are employed there.

Product Type Portfolio:

VARILOC: VARILOC locking compression plate system provides the advantages of locking plate that gives angle stability to get better fixation in osteoporosis and metaphyseal fractures. Its locking mechanism offers better blood supply preservation as compared to conventional plate and screw system. Developed under Medtronic-Kanghui trauma products.

Key Developments: In May 2022, Medtronic plc, leader in healthcare technology announced its acquisition of Intersect ENT. They will expand company's ear, nose and throat portfolio with various innovative products.

The global trauma products market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers:
      • 4.1.1.1. Rising Incidence of traumatic injuries
      • 4.1.1.2. Increasing technological advancements
    • 4.1.2. Restraints:
      • 4.1.2.1. Lack of skilled staff
      • 4.1.2.2. High cost associated with procedures
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Regulatory Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
    • 6.1.2. Market Attractiveness Index, By Product Type Segment
  • 6.2. Internal Fixators
      • 6.2.1.1. Introduction
      • 6.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
      • 6.2.1.3. Plates
      • 6.2.1.4. Screws
      • 6.2.1.5. Nails
      • 6.2.1.6. Other Internal Fixators
  • 6.3. External Fixators
    • 6.3.1. Unilateral & Bilateral Fixators
    • 6.3.2. Circular Fixators
    • 6.3.3. Hybrid Fixators
  • 6.4. Other Trauma Products

7. By Surgical Site

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgical Site Segment
    • 7.1.2. Market Attractiveness Index, By Surgical Site Segment
  • 7.2. Upper Extremities
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 7.2.3. Hand & Wrist
    • 7.2.4. Shoulder
    • 7.2.5. Arms
    • 7.2.6. Elbow
  • 7.3. Lower Extremities
    • 7.3.1. Hip & Pelvic
    • 7.3.2. Lower Leg
    • 7.3.3. Foot & Ankle
    • 7.3.4. Thigh
    • 7.3.5. Knee

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
    • 8.1.2. Market Attractiveness Index, By End User Segment
  • 8.2. Hospitals & Trauma Centers
      • 8.2.1.1. Introduction
      • 8.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Ambulatory Surgery Centers

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgical Site
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgical Site
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgical Site
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgical Site
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. Australia
      • 9.5.6.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgical Site
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Key Developments and Strategies
  • 10.2. Company Share Analysis
  • 10.3. Product Types Benchmarking
  • 10.4. List of Key Companies to Watch

11. Company Profiles

  • 11.1. Medtronic Plc
    • 11.1.1. Company Overview
    • 11.1.2. Product Type Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Cardinal Health Inc.
  • 11.3. Stryker Corporation
  • 11.4. Smith & Nephew
  • 11.5. Depuy Synthes (A part of Johnson & Johnson)
  • 11.6. Zimmer Biomet Holdings Inc.
  • 11.7. Integra Lifesciences Holdings Corporation
  • 11.8. Wright Medical Group N.V
  • 11.9. B. Braun Melsungen AG
  • 11.10. Arthrex, Inc.

LIST NOT EXHAUSTIVE

12. Global Trauma Products Market - DataM

  • 12.1. Appendix
  • 12.2. About Us and End User
  • 12.3. Contact Us